{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:12:54Z","timestamp":1790327574107,"version":"4.1.0"},"reference-count":30,"publisher":"American Diabetes Association","issue":"5","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,5,1]]},"abstract":"<jats:p>Many diabetic patients suffer from a cardiomyopathy that cannot be explained by poor coronary perfusion. Reactive oxygen species (ROS) have been proposed to contribute to this cardiomyopathy. Consistent with this we found evidence for induction of the antioxidant genes for catalase in diabetic OVE26 hearts. To determine whether increased antioxidant protection could reduce diabetic cardiomyopathy, we assessed cardiac morphology and contractility, Ca2+ handling, malondialdehyde (MDA)-modified proteins, and ROS levels in individual cardiomyocytes isolated from control hearts, OVE26 diabetic hearts, and diabetic hearts overexpressing the antioxidant protein catalase. Diabetic hearts showed damaged mitochondria and myofibrils, reduced myocyte contractility, slowed intracellular Ca2+ decay, and increased MDA-modified proteins compared with control myocytes. Overexpressing catalase preserved normal cardiac morphology, prevented the contractile defects, and reduced MDA protein modification but did not reverse the slowed Ca2+ decay induced by diabetes. Additionally, high glucose promoted significantly increased generation of ROS in diabetic cardiomyocytes. Chronic overexpression of catalase or acute in vitro treatment with rotenone, an inhibitor of mitochondrial complex I, or thenoyltrifluoroacetone, an inhibitor of mitochondrial complex II, eliminated excess ROS production in diabetic cardiomyocytes. The structural damage to diabetic mitochondria and the efficacy of mitochondrial inhibitors in reducing ROS suggest that mitochondria are a source of oxidative damage in diabetic cardiomyocytes. We also found that catalase overexpression protected cardiomyocyte contractility in the agouti model of type 2 diabetes. These data show that both type 1 and type 2 diabetes induce damage at the level of individual myocytes, and that this damage occurs through mechanisms utilizing ROS.<\/jats:p>","DOI":"10.2337\/diabetes.53.5.1336","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T14:04:22Z","timestamp":1173189862000},"page":"1336-1343","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":243,"title":["Catalase Protects Cardiomyocyte Function in Models of Type 1 and Type 2 Diabetes"],"prefix":"10.2337","volume":"53","author":[{"given":"Gang","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naira S.","family":"Metreveli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajakumar V.","family":"Donthi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Carlson","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, University of North Dakota, Grand Forks, North Dakota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031218123578000_R1","doi-asserted-by":"crossref","unstructured":"Jaffe AS, Spadaro JJ, Schechtman K, Roberts R, Geltman EM, Sobel BE: Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J\u2008108:31\u201337,1984","DOI":"10.1016\/0002-8703(84)90541-6"},{"key":"2022031218123578000_R2","doi-asserted-by":"crossref","unstructured":"Brown RA, Walsh MF, Ren J: Influence of gender and diabetes on vascular and myocardial contractile function. Endocr Res\u200827:399\u2013408,2001","DOI":"10.1081\/ERC-100107864"},{"key":"2022031218123578000_R3","doi-asserted-by":"crossref","unstructured":"Belke DD, Larsen TS, Gibbs EM, Severson DL: Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db\/db) mice. Am J Physiol Endocrinol Metab\u2008279:E1104\u2013E1113,2000","DOI":"10.1152\/ajpendo.2000.279.5.E1104"},{"key":"2022031218123578000_R4","doi-asserted-by":"crossref","unstructured":"Ren J, Sowers JR, Walsh MF, Brown RA: Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. Am J Physiol Heart Circ Physiol\u2008279:H1708\u2013H1714,2000","DOI":"10.1152\/ajpheart.2000.279.4.H1708"},{"key":"2022031218123578000_R5","doi-asserted-by":"crossref","unstructured":"Fein FS: Diabetic cardiomyopathy (Review). Diabetes Care\u200813:1169\u20131179,1990","DOI":"10.2337\/diacare.13.11.1169"},{"key":"2022031218123578000_R6","doi-asserted-by":"crossref","unstructured":"Zarich SW, Nesto RW: Diabetic cardiomyopathy. Am Heart J\u2008118:1000\u20131012,1989","DOI":"10.1016\/0002-8703(89)90236-6"},{"key":"2022031218123578000_R7","doi-asserted-by":"crossref","unstructured":"Marra G, Cotroneo P, Pitocco D, Manto A, Di Leo MA, Ruotolo V, Caputo S, Giardina B, Ghirlanda G, Santini SA: Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care\u200825:370\u2013375,2002","DOI":"10.2337\/diacare.25.2.370"},{"key":"2022031218123578000_R8","doi-asserted-by":"crossref","unstructured":"Penckofer S, Schwertz D, Florczak K: Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J Cardiovasc Nurs\u200816:68\u201385,2002","DOI":"10.1097\/00005082-200201000-00007"},{"key":"2022031218123578000_R9","doi-asserted-by":"crossref","unstructured":"Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature\u2008404:787\u2013790,2000","DOI":"10.1038\/35008121"},{"key":"2022031218123578000_R10","doi-asserted-by":"crossref","unstructured":"Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN: Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes\u200851:174\u2013181,2002","DOI":"10.2337\/diabetes.51.1.174"},{"key":"2022031218123578000_R11","doi-asserted-by":"crossref","unstructured":"Ye G, Metreveli NS, Ren J, Epstein PN: Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes\u200852:777\u2013783,2003","DOI":"10.2337\/diabetes.52.3.777"},{"key":"2022031218123578000_R12","doi-asserted-by":"crossref","unstructured":"Kang YJ, Zhou ZX, Wu H, Wang GW, Saari JT, Klein JB: Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab Invest\u200880:745\u2013757,2000","DOI":"10.1038\/labinvest.3780078"},{"key":"2022031218123578000_R13","unstructured":"DeMoor JM, Koropatnick DJ: Metals and cellular signaling in mammalian cells. Cell Mol Biol (Noisy-le-grand).\u200846:367\u2013381,2000"},{"key":"2022031218123578000_R14","doi-asserted-by":"crossref","unstructured":"Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED: Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest\u2008109:629\u2013639,2002","DOI":"10.1172\/JCI0213946"},{"key":"2022031218123578000_R15","doi-asserted-by":"crossref","unstructured":"Epstein PN, Overbeek PA, Means AR: Calmodulin-induced early-onset diabetes in transgenic mice. Cell\u200858:1067\u20131073,1989","DOI":"10.1016\/0092-8674(89)90505-9"},{"key":"2022031218123578000_R16","doi-asserted-by":"crossref","unstructured":"Kang YJ, Chen Y, Yu A, Voss-McCowan M, Epstein PN: Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest\u2008100:1501\u20131506,1997","DOI":"10.1172\/JCI119672"},{"key":"2022031218123578000_R17","doi-asserted-by":"crossref","unstructured":"Liang Q, Carlson EC, Borgerding AJ, Epstein PN: A transgenic model of acetaldehyde overproduction accelerates alcohol cardiomyopathy. J Pharmacol Exp Ther\u2008291:766\u2013772,1999","DOI":"10.1016\/S0022-3565(24)35165-1"},{"key":"2022031218123578000_R18","unstructured":"Karnovsky MJ: A formaldehyde-glutaraldehyde fixative for high osmololity for use in electron microscopy. J Cell Biol\u200835:137A\u2013138A,1965"},{"key":"2022031218123578000_R19","doi-asserted-by":"crossref","unstructured":"Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A, Anversa P: IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes\u200850:1414\u20131424,2001","DOI":"10.2337\/diabetes.50.6.1414"},{"key":"2022031218123578000_R20","doi-asserted-by":"crossref","unstructured":"Wohaieb SA, Godin DV: Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat: effects of insulin treatment. Diabetes\u200836:1014\u20131018,1987","DOI":"10.2337\/diabetes.36.9.1014"},{"key":"2022031218123578000_R21","unstructured":"Nishio Y, Taki H, Hidaka H, Kashiwagi A: Altered NF-kB activity and oxidative stress-related gene expression in cardiovascular tissues of diabetic rats. Diabetes\u200846 (Suppl. 1):A206,1997"},{"key":"2022031218123578000_R22","doi-asserted-by":"crossref","unstructured":"Genet S, Kale RK, Baquer NZ: Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonellafoenum graecum). Mol Cell Biochem\u2008236:7\u201312,2002","DOI":"10.1023\/A:1016103131408"},{"key":"2022031218123578000_R23","doi-asserted-by":"crossref","unstructured":"Wohaieb SA, Godin DV: Alterations in tissue antioxidant systems in the spontaneously diabetic (BB Wistar) rat. Can J Physiol Pharmacol\u200865:2191\u20132195,1987","DOI":"10.1139\/y87-346"},{"key":"2022031218123578000_R24","doi-asserted-by":"crossref","unstructured":"Brand MD: Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp Gerontol\u200835:811\u2013820,2000","DOI":"10.1016\/S0531-5565(00)00135-2"},{"key":"2022031218123578000_R25","unstructured":"Du X-L, Edelstein D, Brownlee M: Free fatty acids inhibit endothelial cell prostacyclin production and nitric oxide synthetase (eNOS) activity by inducing mitochondrial superoxide overproduction (Abstract). Diabetes\u200850 (Suppl. 2):A152,2001"},{"key":"2022031218123578000_R26","unstructured":"DiMauro S, Hirano M: Mitochondria and heart disease. Curr Opin Cardiol\u200813:190\u2013197,1998"},{"key":"2022031218123578000_R27","unstructured":"Giacomelli F, Wiener J: Primary myocardial disease in the diabetic mouse: an ultrastructural study. Lab Invest\u200840:460\u2013473,1979"},{"key":"2022031218123578000_R28","doi-asserted-by":"crossref","unstructured":"Lesnefsky EJ, Gudz TI, Migita CT, Ikeda-Saito M, Hassan MO, Turkaly PJ, Hoppel CL: Ischemic injury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys\u2008385:117\u2013128,2001","DOI":"10.1006\/abbi.2000.2066"},{"key":"2022031218123578000_R29","doi-asserted-by":"crossref","unstructured":"Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT: Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem\u2008273:11619\u201311624,1998","DOI":"10.1074\/jbc.273.19.11619"},{"key":"2022031218123578000_R30","doi-asserted-by":"crossref","unstructured":"Dutta K, Podolin DA, Davidson MB, Davidoff AJ: Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes\u200850:1186\u20131192,2001","DOI":"10.2337\/diabetes.50.5.1186"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/53\/5\/1336\/647026\/zdb00504001336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/53\/5\/1336\/647026\/zdb00504001336.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T12:06:48Z","timestamp":1736856408000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/53\/5\/1336\/25890\/Catalase-Protects-Cardiomyocyte-Function-in-Models"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.53.5.1336","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}